New leaders for Mayo Clinic Center for Individualized Medicine
The Mayo Clinic Center for Individualized Medicine discovers and integrates the latest in genomic, omic and clinical sciences into personalized care for each Mayo Clinic patient. The center has appointed three new leaders to focus on clinical implementation, research and innovation, and education. These new leaders will report to Konstantinos Lazaridis, M.D. (I ’96, GI ’00), executive director of the Center for Individualized Medicine.
The new leaders are:
Timothy Curry, M.D., Ph.D., Midwest associate director, Clinical Implementation Medicine, Mayo Clinic in Rochester
Dr. Curry (ANES ’05) has a primary appointment in the Department of Anesthesiology and Perioperative Medicine, where he is vice chair of Practice, and a joint appointment in the Department of Physiology and Biomedical Engineering. He is a professor of anesthesiology, Mayo Clinic College of Medicine and Science.
Dr. Curry’s research focuses on genomic education, machine learning approaches to advanced predictive hemodynamic monitoring, and clinical practice improvement.
Dr. Curry is co-director of the Center for Individualized Medicine’s Clinomics Program and former director of Education for the center. In his new role, he will advance the center’s vision by leading tactical operational conduct and programmatic integration from a clinical implementation perspective.
Eric Klee, Ph.D., Midwest Associate Director, Research and Innovation, Mayo Clinic in Rochester
Dr. Klee (LABM ’05) has an appointment in Quantitative Health Sciences and joint appointments in Clinical Genomics, and Laboratory Medicine and Pathology. He is an associate professor of biomedical informatics, Mayo Clinic College of Medicine and Science.
Dr. Klee leads initiatives centered on innovation to empower clinicians to apply information gathered from molecular-level data to diagnose and treat patients’ medical conditions. His research program focuses on data analytics and translational application development involving multi-omic profiling in patients with rare genetic disease.
He is director of the Center for Individualized Medicine’s Bioinformatics, Omics Data Platform, and Translational Omics programs. He is also a member of Undiagnosed Diseases Network International.
Dr. Klee will lead the center’s tactical operational conduct and programmatic integration from a research and innovation perspective.
Dr. Klee has also been appointed as enterprise co-leader of Cancer Informatics and Data Science, Mayo Clinic Comprehensive Cancer Center.
Mira Keddis, M.D., Director of Education, Mayo Clinic in Arizona
Dr. Keddis (I ’09, CMR ’10, NEPH ’13) has an appointment in the Division of Nephrology. She is an associate professor of medicine, Mayo Clinic College of Medicine and Science.
Dr. Keddis is associate dean of faculty affairs for Mayo Clinic Alix School of Medicine. Her research focuses on kidney stone evaluation and management, with special interest in enteric hyperoxaluria and kidney stone disease in kidney donors and recipients. She has a special interest in health care delivery in the Native American population before and after kidney transplant.
She will lead the center’s Education Program, which delivers genomic education and training in new precision medicine tools and applications for clinical practice.